383 related articles for article (PubMed ID: 8841465)
1. Correlation of DNA ploidy and histologic diagnosis from prostate core-needle biopsies: is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens?
Lo J; Kerns BJ; Amling CL; Robertson CN; Layfield LJ
J Surg Oncol; 1996 Sep; 63(1):41-5. PubMed ID: 8841465
[TBL] [Abstract][Full Text] [Related]
2. Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer.
Ross JS; Sheehan CE; Ambros RA; Nazeer T; Jennings TA; Kaufman RP; Fisher HA; Rifkin MD; Kallakury BV
Am J Surg Pathol; 1999 Mar; 23(3):296-301. PubMed ID: 10078920
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
[TBL] [Abstract][Full Text] [Related]
4. DNA image cytometry of prostatic carcinoma: a comparison of needle core biopsy and subsequent prostatectomy specimens.
Leung CS; Zbieranowski I; Demers J; Murray D
Mod Pathol; 1994 Feb; 7(2):195-9. PubMed ID: 8008743
[TBL] [Abstract][Full Text] [Related]
5. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ
Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452
[TBL] [Abstract][Full Text] [Related]
6. The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer.
Häggarth L; Auer G; Busch C; Norberg M; Häggman M; Egevad L
Scand J Urol Nephrol; 2005; 39(5):387-92. PubMed ID: 16257840
[TBL] [Abstract][Full Text] [Related]
7. Comparison of quantitative histomorphometry and DNA ploidy in tissue sections of prostate carcinoma.
Kay PA; Riehle DL; Cheville JC; Lohse CM; Pankratz VS; Hill EM; Sebo TJ
Anal Quant Cytol Histol; 2002 Feb; 24(1):7-14. PubMed ID: 11865951
[TBL] [Abstract][Full Text] [Related]
8. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.
Ross JS; Nazeer T; Figge HL; Fisher HA; Rifkin MD
Am J Clin Pathol; 1995 Jul; 104(1):36-41. PubMed ID: 7541934
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy of ovarian and adnexal cyst fluid. A useful adjunct to cytology.
Greenebaum E; Yee HT; Liu J
Acta Cytol; 1994; 38(2):201-8. PubMed ID: 8147211
[TBL] [Abstract][Full Text] [Related]
10. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
11. [Flow cytometry in prostate cancer. Evaluation of its feasibility for biopsy specimens and correlation with grading].
Ferrara G; Monaco R; Capasso A; Bellomo PF; Fruttero A; Pugno F; Nappi O; Ruà S
Pathologica; 1998 Feb; 90(1):14-9. PubMed ID: 9628974
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy in seminal vesicle cells. A potential diagnostic pitfall in urine cytology.
Wojcik EM; Bassler TJ; Orozco R
Anal Quant Cytol Histol; 1999 Feb; 21(1):29-34. PubMed ID: 10068772
[TBL] [Abstract][Full Text] [Related]
13. Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancer.
Venkataraman G; Heinze G; Holmes EW; Ananthanarayanan V; Bostwick DG; Paner GP; Bradford-De La garza CM; Brown HG; Flanigan RC; Wojcik EM
Prostate; 2007 Oct; 67(14):1524-36. PubMed ID: 17683063
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of DNA ploidy combined with a cytometric proliferation index of imprints from core needle biopsies in prostate cancer.
Ahlgren G; Falkmer U; Gadaleanu V; Abrahamsson PA
Eur Urol; 1999 Oct; 36(4):314-9. PubMed ID: 10473991
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
16. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
[TBL] [Abstract][Full Text] [Related]
17. Preoperative histological and cytological diagnosis and DNA ploidy assessment of localized prostatic cancer. A comparison between findings in biopsies and total prostatectomy specimens.
Häggman M; de la Torre M; Norberg M; Busch C
APMIS; 1994 Nov; 102(11):841-8. PubMed ID: 7833004
[TBL] [Abstract][Full Text] [Related]
18. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
19. [Multi-core prostatic biopsy].
Rodríguez Duarte C
Arch Esp Urol; 2002 Oct; 55(8):907-14. PubMed ID: 12455281
[TBL] [Abstract][Full Text] [Related]
20. DNA heterogeneity determined by flow cytometry in prostatic adenocarcinoma--necessitating multiple site analysis.
Warzynski MJ; Soechtig CE; Maatman TJ; Goldsmith LC; Grobbel MA; Carothers GG; Shockley KF
Prostate; 1995 Dec; 27(6):329-35. PubMed ID: 7501545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
